Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy

Clinical trial NCT05314296 · UNKNOWN

Trial details

NCT number: NCT05314296
Sponsor: N.N. Blokhin National Medical Research Center of Oncology
Status: UNKNOWN
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer T790M EGFR Gene Mutation

Start date: 2020-06-01
Primary completion: 2022-09-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.